{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:03:53Z","timestamp":1762297433105},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,5,31]],"date-time":"2009-05-31T00:00:00Z","timestamp":1243728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11940-009-0029-1","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T20:04:20Z","timestamp":1243627460000},"page":"253-261","source":"Crossref","is-referenced-by-count":7,"title":["Antiepileptic drugs and other medications: What interactions may arise?"],"prefix":"10.1007","volume":"11","author":[{"given":"Ram","family":"Mani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,31]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2146\/ajhp070508","volume":"65","author":"M. Dickson","year":"2008","unstructured":"Dickson M, Bramley TJ, Kozma C, et al.: Potential drug-drug interactions with antiepileptic drugs in Medicaid recipients. Am J Health Syst Pharm 2008, 65:1720\u20131726.","journal-title":"Am J Health Syst Pharm"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/CBO9780511545023.010","volume-title":"Antiepileptic Drugs: Combination Therapy and Interactions","author":"J. Majkowski","year":"2005","unstructured":"Majkowski J, Patsalos PN: Interactions between antiepileptic and non-antiepileptic drugs. In Antiepileptic Drugs: Combination Therapy and Interactions. Edited by Majkowski J, Bourgeois BFD, Patsalos PN, Mattson RH. New York: Cambridge University Press; 2005:139\u2013176."},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","volume":"2","author":"P.N. Patsalos","year":"2003","unstructured":"Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003, 2:473\u2013481.","journal-title":"Lancet Neurol"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","volume":"61","author":"E. Perucca","year":"2006","unstructured":"Perucca E: Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharm 2006, 61:246\u2013255.","journal-title":"Br J Clin Pharm"},{"key":"29_CR5","first-page":"91","volume":"13","author":"J.R. Pollard","year":"2007","unstructured":"Pollard JR, Delanty N: Antiepileptic drug interactions. Continuum: Epilepsy 2007, 13:91\u2013105.","journal-title":"Continuum: Epilepsy"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","volume":"2","author":"P.N. Patsalos","year":"2003","unstructured":"Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003, 2:347\u2013356.","journal-title":"Lancet Neurol"},{"issue":"Suppl8","key":"29_CR7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1528-1157.2000.tb02944.x","volume":"41","author":"J.A. French","year":"2000","unstructured":"French JA, Gidal BE: Antiepileptic drug interactions. Epilepsia 2000, 41(Suppl 8):S30\u2013S36.","journal-title":"Epilepsia"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1528-1157.1992.tb01772.x","volume":"33","author":"G. Kr\u00e4mer","year":"1992","unstructured":"Kr\u00e4mer G, Tettenborn B, Klosterskov Jensen P, et al.: Oxcarbazepine does not affect the anticoagulant activity of warfarin. Epilepsia 1992, 33:1145\u20131148.","journal-title":"Epilepsia"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/j.1552-4604.1990.tb01854.x","volume":"30","author":"P.E. Nolan Jr","year":"1990","unstructured":"Nolan PE Jr, Marcus FI, Karol MD, et al.: Effect of phenytoin on the clinical pharmacokinetics of amiodarone. J Clin Pharmacol 1990, 30:1112\u20131119.","journal-title":"J Clin Pharmacol"},{"issue":"8483","key":"29_CR10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(86)91099-8","volume":"1","author":"G.J. Macphee","year":"1986","unstructured":"Macphee GJ, McInnes GT, Thompson GG, Brodie MJ: Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet 1986, 1(8483):700\u2013703.","journal-title":"Lancet"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.72.1.114","volume":"72","author":"S.D. Shorvon","year":"2002","unstructured":"Shorvon SD, Tallis RC, Wallace HK: Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice. J Neurol Neurosurg Psychiatry 2002, 72:114\u2013115.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1212\/WNL.67.12_suppl_4.S56","volume":"67","author":"C.L. Harden","year":"2006","unstructured":"Harden CL, Leppik I: Optimizing therapy of seizures in women who use oral contraceptives. Neurology 2006, 67:S56\u2013S58.","journal-title":"Neurology"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.seizure.2007.11.013","volume":"17","author":"A.M. Schwenkhgaen","year":"2008","unstructured":"Schwenkhgaen AM, Stodieck SR: Which contraception for women with epilepsy? Seizure 2008, 17:145\u2013150.","journal-title":"Seizure"},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0001-6349.2005.00759.x","volume":"84","author":"R. Erkkola","year":"2005","unstructured":"Erkkola R, Landgren BM: Role of progestins in contraception. Acta Obset Gynecol Scand 2005, 84:207\u2013216.","journal-title":"Acta Obset Gynecol Scand"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1979.tb04834.x","volume":"20","author":"C.B. Coulam","year":"1979","unstructured":"Coulam CB, Annegers JF: Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979, 20:519\u2013525.","journal-title":"Epilepsia"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","volume":"46","author":"A. Reimers","year":"2005","unstructured":"Reimers A, Helde G, Brodtkorb E: Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 2005, 46:1414\u20131417.","journal-title":"Epilepsia"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1528-1167.2005.00605.x","volume":"46","author":"A.G. Herzog","year":"2005","unstructured":"Herzog AG, Farina EL, Blum AS: Serum valproate levels with oral contraceptive use. Epilepsia 2005, 46:970\u2013971.","journal-title":"Epilepsia"},{"issue":"12Suppl4","key":"29_CR18","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1212\/WNL.67.12_suppl_4.S28","volume":"67","author":"G. Lacerda","year":"2006","unstructured":"Lacerda G, Krummel T, Sabourdy C, et al.: Optimizing therapy of seizures in patients with renal or hepatic dysfunction. Neurology 2006, 67(12 Suppl 4):S28\u2013S33.","journal-title":"Neurology"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0924-977X(99)00033-4","volume":"9","author":"B. Buur-Rasmussen","year":"1999","unstructured":"Buur-Rasmussen B, Br\u00f8ren K: Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacol 1999, 9:453\u2013459.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl2","key":"29_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1528-1157.2002.043s2019.x","volume":"43","author":"S. Koch-Stoecker","year":"2002","unstructured":"Koch-Stoecker S: Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia 2002, 43(Suppl 2):19\u201324.","journal-title":"Epilepsia"},{"issue":"Suppl6","key":"29_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1528-1167.2008.01756.x","volume":"49","author":"J. Desai","year":"2008","unstructured":"Desai J: Perspectives on interactions between antiepileptic drugs (AEDs) and antimicrobial agents. Epilepsia 2008, 49(Suppl 6):47\u201349.","journal-title":"Epilepsia"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.1985.tb05071.x","volume":"20","author":"L. Kay","year":"1985","unstructured":"Kay L, Kampmann JP, Svendsen TL, et al.: Influence of rifampin and isoniazid on the kinetics of phenytoin. Br J Clin Pharmacol 1985, 20:323\u2013326.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl6","key":"29_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1528-1167.2008.01754.x","volume":"49","author":"P. Satishchandra","year":"2008","unstructured":"Satishchandra P, Sinha S: Seizures in HIV-seropositive individuals. NIMHANS experience and review. Epilepsia 2008, 49(Suppl 6):33\u201341.","journal-title":"Epilepsia"},{"issue":"12Suppl4","key":"29_CR24","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.67.12_suppl_4.S19","volume":"67","author":"A.I. Bhigjee","year":"2006","unstructured":"Bhigjee AI, Rosemberg S: Optimizing therapy of seizures in patients with HIV and cysticercosis. Neurology 2006, 67(12 Suppl 4):S19\u2013S22.","journal-title":"Neurology"},{"issue":"3Pt1","key":"29_CR25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1212\/WNL.42.3.492","volume":"42","author":"P.R. Bittencourt","year":"1992","unstructured":"Bittencourt PR, Gracia CM, Martins R, et al.: Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology 1992, 42(3 Pt 1):492\u2013496.","journal-title":"Neurology"},{"key":"29_CR26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","volume":"39","author":"H. Mori","year":"2007","unstructured":"Mori H, Takahashi K, Mizutani T: Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev 2007, 39:647\u2013657.","journal-title":"Drug Metab Rev"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/ebeh.2000.0031","volume":"1","author":"C.T. Peebles","year":"2000","unstructured":"Peebles CT, McAuley JW, Roach J, et al.: Alternative medicine use by patients with epilepsy. Epilepsy Behav 2000, 1:74\u201377.","journal-title":"Epilepsy Behav"},{"key":"29_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1528-1167.2007.01379.x","volume":"49","author":"N. Samuels","year":"2008","unstructured":"Samuels N, Finkelstein Y, Singer SR, Oberbaum M.: Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia 2008, 49:373\u2013380.","journal-title":"Epilepsia"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.67.12_suppl_4.S10","volume":"67","author":"C.J. Vecht","year":"2006","unstructured":"Vecht CJ, van Breemen M: Optimizing therapy of seizures in patients with brain tumors. Neurology 2006, 67:S10\u2013S13.","journal-title":"Neurology"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S. Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, et al.: P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 2005, 72:255\u2013260","journal-title":"J Neurooncol"},{"key":"29_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(00)02503-4","volume":"356","author":"M.V. Relling","year":"2000","unstructured":"Relling MV, Pui CH, Sandlund JT, et al.: Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000, 356:285\u2013290.","journal-title":"Lancet"},{"issue":"12Suppl4","key":"29_CR32","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1212\/WNL.67.12_suppl_4.S34","volume":"67","author":"D.R. Chabolla","year":"2006","unstructured":"Chabolla DR, Wszolek ZK: Pharmacologic management of seizures in organ transplant. Neurology 2006, 67(12 Suppl 4):S34\u2013S38.","journal-title":"Neurology"},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11940-008-0026-9","volume":"10","author":"I.E. Leppik","year":"2008","unstructured":"Leppik IE: Treatment of epilepsy in the elderly. Curr Treat Options Neurol 2008, 10:239\u2013245.","journal-title":"Curr Treat Options Neurol"},{"key":"29_CR34","first-page":"1177","volume-title":"Textbook of Clinical Neurology","author":"N. Foldavary-Shaefer","year":"2003","unstructured":"Foldavary-Shaefer N, Wyllie E: Neuropharmacology of the antiepileptic drugs. In Textbook of Clinical Neurology, edn 2. Edited by Goetz CG. New York: Saunders; 2003:1177\u20131181.","edition":"edn 2"},{"key":"29_CR35","first-page":"1235","volume-title":"Epilepsy: A Comprehensive Textbook","author":"R.H. Levy","year":"2008","unstructured":"Levy RH, Bourgeois BFD, Hachad H: Drug-drug interactions. In Epilepsy: A Comprehensive Textbook. Edited by Engel J Jr, Pedley TA. Philadelphia: Lippincott Williams & Wilkins; 2008:1235\u20131248."},{"key":"29_CR36","first-page":"1257","volume-title":"Melmon and Morrelli\u2019s Clinical Pharmacology: Basic Principles in Therapeutics","author":"J.M. Wright","year":"2000","unstructured":"Wright JM: Drug interactions. In Melmon and Morrelli\u2019s Clinical Pharmacology: Basic Principles in Therapeutics, edn 4. Edited by Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW. New York: McGraw-Hill; 2000:1257\u20131266.","edition":"edn 4"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-009-0029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-009-0029-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-009-0029-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:54Z","timestamp":1559422614000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-009-0029-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,31]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s11940-009-0029-1","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,31]]}}}